Properties of small molecules affecting insulin receptor function

Area of Science:

• Biochemistry
• Pharmacology
• Endocrinology

Background:

• Oral small molecules with insulin mimetic effects are sought to replace insulin injections for diabetes management.
• Identifying compounds that mimic insulin's interaction with the insulin receptor (IR) is a key research area.

Purpose of the Study:

• To discover small molecules with oral availability that exhibit insulin mimetic effects.
• To identify compounds that interact with a specific insulin epitope involved in insulin receptor binding.

Main Methods:

• Database searches for insulin mimetic compounds.
• Displacement assays to assess binding to the insulin receptor (IR).
• Spectroscopic techniques (NMR, UV-vis, fluorescence) to characterize ligand-receptor interactions.
• Lipogenesis assays in adipocytes.

Main Results:

• Thymolphthalein identified as a weak insulin receptor (IR) agonist, displacing insulin and stimulating IR phosphorylation.
• Thymolphthalein potentiates insulin-stimulated lipogenesis in adipocytes at 10(-5)-10(-3) M concentrations.
• Phenol red and fluorescein analogues displaced insulin from the IR ectodomain but lacked agonistic effects.
• Spectroscopic analysis confirmed ligand binding to IR fragments with similar affinities.
• Multiple ligand binding sites on the IR were identified, with one overlapping the insulin binding site.

Conclusions:

• Thymolphthalein demonstrates partial insulin activity through interaction with the insulin receptor (IR).
• Further investigation of thymolphthalein and related compounds may lead to novel oral diabetes therapies.
• Understanding the binding interactions provides insights into insulin receptor (IR) modulation.